Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A bone replaceable artificial bone substitute: osteoinduction by combining with bone inducing agent.

H Suh1, D W Han, J C Park

  • 1Department of Medical Engineering and Department of Orthopedic Surgery, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-ku, Seoul 120-752, Korea. hwal@yumc.yonsei.ac.kr

Artificial Organs
|July 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of several biomarkers associated with diabetic nephropathy.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2014
Same author

Fungal peri-prosthetic joint infection after primary total knee replacement.

The Journal of bone and joint surgery. British volume·2012
Same author

Brain atrophy in primary lateral sclerosis.

Neurology·2009
Same author

Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.

Bone marrow transplantation·2009
Same author

5,7-dihydroxy-3,4,6-trimethoxyflavone inhibits the inflammatory effects induced by Bacteroides fragilis enterotoxin via dissociating the complex of heat shock protein 90 and I kappaB alpha and I kappaB kinase-gamma in intestinal epithelial cell culture.

Clinical and experimental immunology·2009
Same author

New-onset systemic lupus erythematosus during chronic dialysis and after transplantation for idiopathic renal failure.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

A novel bone substitute incorporating a bone-inducing agent (BIA) significantly enhanced bone regeneration in rabbit radii defects. This osteoinductive material promoted faster healing and complete bone replacement compared to controls.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Orthopedic Research

Background:

  • Development of effective bone substitutes is crucial for treating bone defects.
  • Carbonate apatite (CAp) and Type I atelocollagen (AtCol) form a promising scaffold.
  • Incorporating osteoinductive agents can enhance bone regeneration.

Purpose of the Study:

  • To prepare and evaluate an osteoinductive bone substitute by combining CAp-AtCol with a bone-inducing agent (BIA).
  • To assess the in vitro osteoblast response to the CAp-AtCol-BIA substitute.
  • To investigate the in vivo bone regeneration capacity of the CAp-AtCol-BIA substitute in a rabbit radius defect model.

Main Methods:

  • A bone substitute was prepared using carbonate apatite (CAp) and Type I atelocollagen (AtCol) with an isolated bone-inducing agent (BIA).

Related Experiment Videos

  • In vitro studies assessed osteoblast attachment, proliferation, and alkaline phosphatase (ALP) activity on the CAp-AtCol-BIA substitute.
  • In vivo studies implanted the CAp-AtCol-BIA substitute into rabbit radial defects and evaluated bone regeneration radiologically and histologically.

    • Main Results:

    • BIA significantly increased osteoblast alkaline phosphatase (ALP) activity in vitro.
    • Osteoblasts cultured on the CAp-AtCol-BIA substitute showed enhanced proliferation and ALP activity, with notable morphological changes.
    • In vivo, the CAp-AtCol-BIA substitute led to complete bone regeneration in rabbit radial defects within 4 weeks, while the control substitute showed partial resorption.

    Conclusions:

    • The developed CAp-AtCol-BIA bone substitute exhibits significant osteoinductive properties.
    • This enhanced bone substitute promotes superior in vitro osteoblast response and in vivo bone regeneration.
    • The CAp-AtCol-BIA substitute represents a promising material for orthopedic applications requiring bone repair.